There are a number of Medication Management Programs under the Fifth Community Pharmacy Agreement. These Programs are:

MedsCheck and Diabetes MedsCheck

Funding of up to $29.6 million is provided under the Fifth Community Pharmacy Agreement (5CPA) for the Medicines Use Review Program (known as MedsCheck) and also funding of up to $12.2 million for the Diabetes Medication Management Service Program (known as Diabetes MedsCheck).

MedsCheck and Diabetes MedsCheck (MedsCheck services) provide for an in-pharmacy review of consumers who are taking multiple medications and/or have newly diagnosed or poorly controlled type 2 diabetes. These services are aimed at enhancing the quality use of medicines and reducing the number of adverse drug events experienced by consumers.

Home Medicines Review

Funding of up to $52.11 million is provided under the Fifth Community Pharmacy Agreement (5CPA) for the Home Medicines Review (HMR) program. The HMR program is designed to assist individuals living at home to maximise the benefits of their medicine regimen and prevent medication related problems.

A HMR service is available to patient’s living in the community whose General Practitioner (GP) determines that a HMR is clinically necessary to optimise the quality use of medicines and to address the patient’s needs.

Residential Medication Management Review

Funding of up to $70 million is provided under the Fifth Community Pharmacy Agreement (5CPA) for the Residential Medication Management Review (RMMR) program. The RMMR program aims to enhance the quality use of medicines, and reduce the number of adverse medicines events by assisting residents and their carers with their medication regimens.

An RMMR service is provided to a permanent resident of an Australian Government funded residential aged care facility, including those in flexible care arrangements (transitional care facilities), who are not eligible for a Home Medicines Review (HMR).